Purchase Order 75N92022P00066

Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the National Institutes of Health's National Institute on Drug Abuse. The $598,190 delivery order is for the synthesis and distribution of opioid and related peptides over the one year period of performance from February 15, 2024 through February 14, 2025. The underlying indefinite delivery contract, awarded in 2022...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,610 firm fixed price purchase order to JPT Peptide Technologies GmbH of Germany. The contract is to provide 20 units of a 158-peptide mixture and 25 units of a 102-peptide mixture related to the SARS-CoV-2 spike glycoprotein and nucleocapsid phosphoprotein, respectively, as referenced in the original solicitation. The peptides will support ongoing NIAID...

This is a cost-plus-fixed-fee task order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs. The contract, valued at $595,094.00, is for the synthesis and distribution of opioid and related peptides over a one-year period of performance from February 15, 2025, to February 14, 2026. This task order is part of a larger $2,781,317...

The Department of Health and Human Services' National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm-fixed-price purchase order to Protein Technologies Inc. (PTI), a manufacturer of peptide synthesis and bioanalytical technology equipment, to acquire a PurePep Chorus UV-IR peptide synthesizer for $107,107.16. The award provides for onsite installation and a startup kit. The purchase is made using simplified acquisition procedures and...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., a minority-owned for-profit organization, to provide HIV-1 peptides. The potential value of this contract is $12,801.20 and the period of performance ends on June 11, 2018. This award was not set aside for small businesses. Peptide 2.0 Inc. specializes in custom...

<p>Genscript USA Inc. has been awarded a $11,395.74 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide purified peptide services. The one-year contract, which runs from July 2023 through July 2024, will support NIH/NIAID's research efforts. No subcontractors or set aside designations were identified. Genscript will perform the peptide purification work at its facility in Piscataway, New Jersey.</p>

The National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, awarded a $14,562 firm fixed-price purchase order to A1 Biochem Labs LLC, a small business, to provide the specialized chemical compound 1,3-dimesityl-4,5-bis(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-4,5-dihydro-1H-imidazol-3-ium chloride. This purchase order supports research related to the agency's SABRE project and has a completion date of April 2, 2025. The contract was not...

This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to A &amp; A Labs LLC, doing business as Synthetic Biomolecules. The $8,482.00 contract is for the custom synthesis of 15-mer peptides. The contract is set aside for small businesses and the awardee is a minority-owned, self-certified small disadvantaged business. The place of performance is San Diego,...

This is a $81,460 firm fixed price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Pepscan Presto B.V., a foreign-owned for-profit company. The contract is for the acquisition, characterization, and optimization of constrained peptides targeting glypican, in support of the NCI's Molecular Imaging Program. The work will involve creating peptide libraries,...

This is a $27,384.76 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of 3 batches/shipments of 60 units each of the intravenous stable isotope D5 glycerol, which is required for metabolic research studies conducted...